• Français
  • Search
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2020 – 2025
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Sponsors & Exhibitors
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • CAHR Board Trainee
    • Become a Member
    • CAHR Strategic Plan 2020 – 2025
    • CAHR Annual General Meeting
    • Call for Nominations: CAHR Board of Directors
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media

Webinar: Professional Development for Mid-Career ID Researchers

 

In partnership with the Canadian Foundation for Infectious Diseases (CFID) and CIHR’s Institute of Infection and Immunity (III) and HIV/AIDS Research Initiative, CAHR will be hosting a virtual Professional Development Workshop for Infectious Disease researchers.  This workshop will offer participants the chance to learn from those with a wealth of experience in such domains as academic leadership, commercializing research, building consortiums and networks, and communicating effectively with decision-makers.

This engaging webinar series will be co-chaired by Dr. Curtis Cooper from the University of Ottawa and Dr. Keith Fowke from the University of Manitoba. Over the course of two days, the program will feature 4-5 speakers, and participants will be invited to take part in discussions and Q&A with each presenter.

To participate in this workshop which is targeted to mid-career infectious disease researchers, please email trainingandawards@cahr-acrv.ca

 

Registration: Complimentary

Dates: October 22 and October 23, 2020

Agenda (subject to change)

 

Speakers

 

Dr. Curtis Cooper, University of Ottawa
Co-Chair

Dr. Cooper trained at the University of Saskatchewan (MD 1994). He received certification in
Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba.
He completed an HIV Research Fellowship and Masters of Epidemiology in 2002 while at the
University of Ottawa. He is currently an Associate Professor with the University of Ottawa,
Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases, Scientist
with the Ottawa Health Research Institute, Director of the Ottawa Hospital and Regional Viral Hepatitis Program and President for the Canadian Foundation for Infectious Diseases. As a clinical researcher, his research activities encompass viral hepatitis, HIV and vaccine development. His work is focused on the development of new therapeutic agents and the delivery of treatment that maximizes safety, adherence and effectiveness.
 

Dr. Keith Fowke, University of Manitoba
Co-Chair and Speaker

Dr. Fowke received his PhD in Medical Microbiology (1995) from the University of Manitoba (UM) and did a postdoctoral fellowship at the National Institutes of Health in Bethesda, Maryland (1995-1999).   In 1999 he was recruited to the UM’s Department of Medical Microbiology and Infectious Diseases and is currently a full professor and the Head of the Department.  He is also cross-appointed with the University of Nairobi’s Department of Medical Microbiology.  Current studies include preventing HIV infections by reducing inflammation at the genital tract, understanding how to block the negative effects of elevated immune checkpoint inhibitors in HIV infection to restore the immune response to full capabilities, and determining the effect of solvent use on the immune system and implications on HIV susceptibility.  Dr. Fowke has a particular interest in training young investigators in multi-disciplinary research and has been involved in a number of workshops and international training programs.  He is the current Chair of the CIHR HIV/AIDS STBBI Research Advisory Committee (CHARAC).

 

Dr. David Evans, University of Alberta
Speaker

Dr. David Evans is a virologist with diverse interests in poxvirus biology as well as a former research administrator. His work is supported by a network of collaborations and commercial contracts and his academic studies have been funded by MRC/CIHR since 1987. Dr. Evans is considered an international leader in the study of poxviruses with special expertise in virus recombination, antiviral drugs, and replication.

Dr. Evans has also demonstrated a longstanding commitment to research translation. His recombineering technology is licensed as InFusion® kits. More recently his research has focussed on developing oncolytic viruses for treating bladder cancer as well as methods for assembling synthetic poxviruses. He has applied for, or holds, international patents relating to these and other technologies.

Dr. Evans’ activities have also helped develop the University of Alberta’s focus on virus research. In 2006 he was awarded $24.9 million to build and equip new research facilities supporting immunology and infectious disease research in Edmonton and Calgary. This included Alberta’s only academic BSL3 laboratory which has since proven its value supporting intensive Covid-19 research activity. In 2010 the University of Alberta was gifted with $25 million to support virus research, and these and other projects were consolidated to create the Li Ka-Shing Institute of Virology. Drs. Evans has also accumulated many years of service on grant panels; reviews and also consults privately. He was a longstanding member of the WHO smallpox advisory committee. Most recently he conducted site visits for the FAO/OIE and served on the Canadian advisory committee on human pathogens and toxins.
 

Dr. Charu Kaushic, McMaster University, CIHR Institute of Infection and Immunity
Speaker

Charu Kaushic is a tenured Full Professor in the Department of Pathology and Molecular Medicine in McMaster University, Hamilton, Canada. She joined as faculty in McMaster University in 2002, where she has done extensive teaching and training and built an interdisciplinary research program for last 18 years. Her research interest is women’s reproductive health, specifically basic, clinical, and translational research examining susceptibility and immune responses to sexually transmitted viruses, HIV-1 and HSV-2. Charu’s research has been funded by CIHR, CFI, CANFAR and OHTN and she has received numerous national and international awards. She is also the Scientific Director of the Canadian Institutes of Health Research (CIHR)-Institute of Infection and Immunity. In this role, she is responsible for making decisions for CIHR strategic investments in infection and immunity, nationally and internationally. She also represents CIHR and Government of Canada at various national and international forums related to infectious diseases. Charu has special interest in championing STEM careers and leadership roles for women.
 

Dr. Guido van Marle, University of Calgary
Speaker

Guido van Marle, MSc, PhD is an Associate professor in the Department of Microbiology, Immunology and Infectious Diseases, and the Director Biomedical Sciences for the Bachelor of Health Sciences program at the Cumming School of Medicine at University of Calgary, He is a molecular virologist and works on HIV/AIDS, HBV and HPV. In addition, he works on research and educational capacity building in Central America and East Africa.

 

Thank you to our Sponsors:

 

 

 

 

 

Our Mission

  • Promote excellence in HIV research
  • Foster collaboration and cooperation among HIV research communities, including basic science, clinical science, epidemiology & public health and social science
  • Promote education and the development of new researchers
  • Provide a unified voice for Canadian HIV researchers and engage diverse stakeholders (community, industry, Government, NGO’s etc.) in ongoing dialogue and knowledge exchange to ensure that HIV research remains responsive to their needs
CAHR 2023 Conference Logo

CAHR 2023
April 27 to 30, 2023

Learn More

Recent News

  • Congratulations! @CANFAR twitter.com/SFU_FHS/status…
  • #CAHR2023 - Ancillary Events / #ACRV2023 - Événements connexes myemail.constantcontact.com/CAHR-2023---An…
  • CAHR extends its thanks to all Sponsors of the CAHR 2023 Conference. Learn more on our website, or visit them in the exhibit hall at the conference : cahr-acrv.ca/conference/spo… #CAHR2023 https://t.co/xEI7YTmvUB
  • L'ACRV adresse ses remerciements à tous les commanditaires du congrès ACRV 2023. Vous en saurez plus à leur sujet en consultant notre site Web ou en leur rendant visite à la salle des exposants du congrès : cahr-acrv.ca/fr/congres/spo… qGwC #ACR https://t.co/XIPkTSSQ39
  • For those developing a CAHR 2023 poster or interested in refining your presenting skills, CAHR has an online tutorial that aims to provide you with tips to make your poster one to remember. Click here: rise.articulate.com/share/n61pMfDF… #CAHR2023
  • Résultats du concours de bourses de voyage pour professionnels de la santé – 2023
Subscribe to the CAHR Newsletter

About CAHR

With a membership of more than 1,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. CAHR is the organizing body for the Annual Canadian Conference on HIV/AIDS Research (CAHR Conference).

CAHR encourages Canadian researchers to be leaders in knowledge translation and to effectively respond both to the Canadian and global HIV/AIDS epidemics. Since its founding in 1991, CAHR has promoted excellence in HIV research, including mentorship and career development of investigators entering the field.

CAHR fosters collaboration and co-operation among HIV research communities, including basic, clinical and social sciences, epidemiology and public health. CAHR also engages people living with HIV/AIDS and AIDS service organizations in ongoing dialogue and information exchange to ensure that HIV/AIDS research remains responsive to the epidemic and its stakeholders.

CAHR is a registered charity.

Links

  • Who We Are
  • Conference
  • Awards
  • Workshops
  • Featured Researchers
  • Student Profiles
  • CAHR News

Contact

For more information or to make a comment, please contact us:

Canadian Association for HIV Research

440 Laurier Avenue West, Suite 200
Ottawa, Ontario K1R 7X6

1-888-374-CAHR (2247)
info@cahr-acrv.ca
  • Media
  • Contact
  • Français